Probiotics in IBD: mucosal and systemic routes of administration may promote similar effects.
作者信息
Foligné B, Grangette C, Pot B
出版信息
Gut. 2005 May;54(5):727-8.
Abstract
摘要
相似文献
1
Probiotics in IBD: mucosal and systemic routes of administration may promote similar effects.
Gut. 2005 May;54(5):727-8.
2
Anti-inflammatory potential of the probiotic dietary supplement Lactibiane Tolérance: in vitro and in vivo considerations.
Clin Nutr. 2006 Dec;25(6):994-1003. doi: 10.1016/j.clnu.2006.03.006. Epub 2006 May 15.
3
Probiotics in inflammatory bowel disease: yet another mechanism of action?
Gastroenterology. 2006 Dec;131(6):2009-12. doi: 10.1053/j.gastro.2006.10.051.
4
Homeostatic effects of TLR9 signaling in experimental colitis.
Ann N Y Acad Sci. 2006 Aug;1072:351-5. doi: 10.1196/annals.1326.022.
5
Inflammatory bowel disease: current insights into pathogenesis and new therapeutic options; probiotics, prebiotics and synbiotics.
Int J Food Microbiol. 2007 Apr 1;115(1):1-11. doi: 10.1016/j.ijfoodmicro.2006.10.006. Epub 2006 Nov 28.
6
Inflammatory bowel disease, a dysregulated host-microbiota interaction: are probiotics a new therapeutic option?
J Gastroenterol Hepatol. 2008 Dec;23(12):1777-9. doi: 10.1111/j.1440-1746.2008.05685.x.
7
Oral feeding of Bifidobacterium bifidum (BGN4) prevents CD4(+) CD45RB(high) T cell-mediated inflammatory bowel disease by inhibition of disordered T cell activation.
Clin Immunol. 2007 Apr;123(1):30-9. doi: 10.1016/j.clim.2006.11.005. Epub 2007 Jan 10.
8
Anti-inflammatory effect of yoghurt in an experimental inflammatory bowel disease in mouse.
J Dairy Res. 2008 Nov;75(4):497-504. doi: 10.1017/S0022029908003579.
9
The S1P receptor modulator FTY720 prevents the development of experimental colitis in mice.
Oncol Rep. 2006 Oct;16(4):699-703.
10
Saccharomyces boulardii inhibits inflammatory bowel disease by trapping T cells in mesenteric lymph nodes.
Gastroenterology. 2006 Dec;131(6):1812-25. doi: 10.1053/j.gastro.2006.10.001.
引用本文的文献
1
Lactobacillus rhamnosus Affects Rat Peritoneal Cavity Cell Response to Stimulation with Gut Microbiota: Focus on the Host Innate Immunity.
Inflammation. 2021 Dec;44(6):2429-2447. doi: 10.1007/s10753-021-01513-z. Epub 2021 Sep 10.
2
Novel and established intestinal cell line models - An indispensable tool in food science and nutrition.
Trends Food Sci Technol. 2011 Nov;22:S11-S20. doi: 10.1016/j.tifs.2011.03.010. Epub 2011 Apr 9.
3
Prophylactic effect of probiotics on the development of experimental autoimmune myasthenia gravis.
PLoS One. 2012;7(12):e52119. doi: 10.1371/journal.pone.0052119. Epub 2012 Dec 20.
4
Mucosal immunology and probiotics.
Curr Allergy Asthma Rep. 2013 Feb;13(1):19-26. doi: 10.1007/s11882-012-0313-0.
5
Intestinal dendritic cells in the pathogenesis of inflammatory bowel disease.
World J Gastroenterol. 2011 Sep 7;17(33):3761-75. doi: 10.3748/wjg.v17.i33.3761.
6
Probiotic yeasts: anti-inflammatory potential of various non-pathogenic strains in experimental colitis in mice.
World J Gastroenterol. 2010 May 7;16(17):2134-45. doi: 10.3748/wjg.v16.i17.2134.
7
Current concepts regarding the pathogenesis of necrotizing enterocolitis.
Pediatr Surg Int. 2009 Apr;25(4):309-18. doi: 10.1007/s00383-009-2344-8. Epub 2009 Mar 20.
8
Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients.
Proc Natl Acad Sci U S A. 2008 Oct 28;105(43):16731-6. doi: 10.1073/pnas.0804812105. Epub 2008 Oct 20.
9
Genes involved in obesity: Adipocytes, brain and microflora.
Genes Nutr. 2006 Sep;1(3-4):189-212. doi: 10.1007/BF02829968.
10
Feeding our immune system: impact on metabolism.
Clin Dev Immunol. 2008;2008:639803. doi: 10.1155/2008/639803.
本文引用的文献
1
Recommendations for improved use of the murine TNBS-induced colitis model in evaluating anti-inflammatory properties of lactic acid bacteria: technical and microbiological aspects.
Dig Dis Sci. 2006 Feb;51(2):390-400. doi: 10.1007/s10620-006-3143-x.
2
Discussion on toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis.
Gastroenterology. 2004 Jul;127(1):366-7; author reply 367. doi: 10.1053/j.gastro.2004.05.052.
3
Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis.
Gastroenterology. 2004 Feb;126(2):520-8. doi: 10.1053/j.gastro.2003.11.019.
4
Contrasting activity of cytosin-guanosin dinucleotide oligonucleotides in mice with experimental colitis.
Clin Exp Immunol. 2003 Nov;134(2):217-24. doi: 10.1046/j.1365-2249.2003.02288.x.
5
Probiotics as biotherapeutic agents: present knowledge and future prospects.
Curr Pharm Des. 2003;9(2):175-91. doi: 10.2174/1381612033392224.
6
Inhibition of leukotriene synthesis markedly accelerates healing in a rat model of inflammatory bowel disease.
Gastroenterology. 1989 Jan;96(1):29-36. doi: 10.1016/0016-5085(89)90760-9.
7
Interferon induction by Lactobacillus bulgaricus and Streptococcus thermophilus in mice.
Eur Cytokine Netw. 1991 Aug-Sep;2(4):299-303.
Zotero 插件